1. Home
  2. KLXE vs SCYX Comparison

KLXE vs SCYX Comparison

Compare KLXE & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KLX Energy Services Holdings Inc.

KLXE

KLX Energy Services Holdings Inc.

HOLD

Current Price

$1.63

Market Cap

51.1M

Sector

Energy

ML Signal

HOLD

Logo SCYNEXIS Inc.

SCYX

SCYNEXIS Inc.

HOLD

Current Price

$5.21

Market Cap

51.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KLXE
SCYX
Founded
2018
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.1M
51.1M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
KLXE
SCYX
Price
$1.63
$5.21
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
451.9K
247.1K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.36
EPS
N/A
N/A
Revenue
$636,600,000.00
$257,000.00
Revenue This Year
$3.89
N/A
Revenue Next Year
$4.95
$608.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.41
$0.57
52 Week High
$4.50
$5.62

Technical Indicators

Market Signals
Indicator
KLXE
SCYX
Relative Strength Index (RSI) 36.08 61.44
Support Level $1.49 $4.65
Resistance Level $2.57 $5.58
Average True Range (ATR) 0.14 0.38
MACD -0.02 -0.00
Stochastic Oscillator 25.25 69.03

Price Performance

Historical Comparison
KLXE
SCYX

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a growth-oriented provider of diversified oilfield services to onshore oil and natural gas exploration and production (E&P) companies operating in both conventional and unconventional plays in all of the active basins throughout the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Southwest region.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: